Hodgkin Disease

"Hodgkin Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Descriptor ID	D006689
MeSH Number(s)	C04.557.386.355 C15.604.515.569.355 C20.683.515.761.355
Concept/Terms	Hodgkin Disease Hodgkin Disease Disease, Hodgkin Granuloma, Hodgkin's Hodgkin's Granuloma Granuloma, Hodgkins Hodgkins Granuloma Lymphogranuloma, Malignant Lymphogranulomas, Malignant Malignant Lymphogranuloma Malignant Lymphogranulomas Hodgkin Lymphoma Lymphoma, Hodgkin Hodgkin's Disease Disease, Hodgkin's Hodgkin's Lymphoma Hodgkins Lymphoma Lymphoma, Hodgkin's Hodgkins Disease Disease, Hodgkins Granuloma, Hodgkin Hodgkin Granuloma Granuloma, Malignant Malignant Granuloma Malignant Granulomas Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Nodular Lymphocyte Predominant Hodgkin's Lymphoma Nodular Sclerosing Hodgkin's Lymphoma Lymphocyte-Rich Classical Hodgkin's Lymphoma Lymphocyte-Rich Classical Hodgkin's Lymphoma Lymphocyte Rich Classical Hodgkin's Lymphoma Mixed Cellularity Hodgkin's Lymphoma Mixed Cellularity Hodgkin's Lymphoma Hodgkin Lymphoma, Adult Hodgkin Lymphoma, Adult Adult Hodgkin Lymphoma Lymphocyte Depletion Hodgkin's Lymphoma Lymphocyte Depletion Hodgkin's Lymphoma

Below are MeSH descriptors whose meaning is more general than "Hodgkin Disease".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Hodgkin Disease [C04.557.386.355]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Hodgkin Disease [C15.604.515.569.355]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Hodgkin Disease [C20.683.515.761.355]

Below are MeSH descriptors whose meaning is related to "Hodgkin Disease".

Below are MeSH descriptors whose meaning is more specific than "Hodgkin Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hodgkin Disease" by people in this website by year, and whether "Hodgkin Disease" was a major or minor topic of these publications.

Bar chart showing 15 publications over 12 distinct years, with a maximum of 2 publications in 2007 and 2010 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
1995	0	1	1
2001	1	0	1
2002	1	0	1
2004	0	1	1
2006	0	1	1
2007	2	0	2
2010	0	2	2
2011	1	0	1
2013	2	0	2
2014	0	1	1
2015	1	0	1

Below are the most recent publications written about "Hodgkin Disease" by people in Profiles.

Hathaway AR, Amadon JP, Keith BA. When Hodgkin comes to a head: Hodgkin central nervous system involvement. Am J Med Sci. 2015 Jun; 349(6):552-3.

View in: PubMed
Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL. Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014 Aug 15; 120(16):2464-71.

View in: PubMed
Xavier AC, Armeson KE, Hill EG, Costa LJ. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors. Cancer. 2013 Sep 15; 119(18):3385-92.

View in: PubMed
Bernatsky S, Ramsey-Goldman R, Joseph L, Boivin JF, Costenbader KH, Urowitz MB, Gladman DD, Fortin PR, Nived O, Petri MA, Jacobsen S, Manzi S, Ginzler EM, Isenberg D, Rahman A, Gordon C, Ruiz-Irastorza G, Yelin E, Bae SC, Wallace DJ, Peschken CA, Dooley MA, Edworthy SM, Aranow C, Kamen DL, Romero-Diaz J, Askanase A, Witte T, Barr SG, Criswell LA, Sturfelt GK, Blanco I, Feldman CH, Dreyer L, Patel NM, St Pierre Y, Clarke AE. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014 Jan; 73(1):138-42.

View in: PubMed
Post GR, Escoto H, Kalpatthi R, Lazarchick J. Osseous Hodgkin lymphoma: a rare presentation and diagnostic challenge. J Pediatr Hematol Oncol. 2011 Jul; 33(5):399-400.

View in: PubMed
Adams B, Lazarchick J, Medina AM, Willner IR, Neville B, Murphy E, Stuart R, Costa LJ. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Am J Hematol. 2010 Aug; 85(8):627-9.

View in: PubMed
Desouki MM, Post GR, Cherry D, Lazarchick J. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res. 2010 Jul; 8(2):84-8.

View in: PubMed
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, Hess AD, Vogelsang GB. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant. 2007 Oct; 13(10):1185-91.

View in: PubMed
Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. 2007 Jun; 137(6):545-52.

View in: PubMed
Wall RJ, Schnapp LM. Radiation pneumonitis. Respir Care. 2006 Nov; 51(11):1255-60.

View in: PubMed

People

Explore

Similar Concepts

Top Journals